Pharmaceuticals, diabetes and beer?

Yes, you wouldn't think that anyone would consider beer as a potential treatment for diabetes!  To be fair, we're actually looking at hops and to be even more specific, a hops-derived compound.

They've discovered that the hops found in beer can be broken down and spun out into therapeutic molecules, regulating body weight and glucose metabolism.

From Lab to Market: CUSPE Lecture, Friday 14 March 2014 (Cambridge)

As ever CUSPE attracted a great audience from all walks of life, a wide age range and a variety of backgrounds.  In fact the audience was a pretty good representation of the types of people needed to make up a good team in order to take a product “from Lab to Market”.  Read on to learn more!

There was a good line up of speakers for this event:

“Threats to everyone everywhere, is a threat to the individual anywhere”

Quote by Dr Margaret Hamburg, 21st Commissioner of the US FDA at the MHRA Annual Lecture, Royal College of Physicians (London), 6 March 2014

The Daily Telegraph states “We’ve cracked it”

Yes on 30 January 2014, this well respected newspaper headlined on its front page “We’ve cracked it: scientists announce breakthrough treatment for nut allergies”.  For such a small nut, this peanut therapy was certainly making some waves. 

A tribute to Professor Man Fong Mei: A pioneer in Chinese medicine and East-West integration

On Saturday 1 February 2014 the Directors of Global Regulatory Services (GRS), Bobby and Greer Deal, joined the Mei family to honour and celebrate “Benny’s” life and also to welcome in the year of the Green Wooden Horse

Research – Greer Deal's firsthand experience as a ‘patient’

One day, I received a letter from my doctor inviting me to take part in some research.  I thought “why not?  I’m always dealing with the regulatory compliance side of research so let’s see what it’s like to be on the receiving end as an active participant.”

Are CROs driving job creation in life sciences?

This was the debate arranged by One Nucleus and hosted by Deloitte in Cambridge on 27 November 2013.  Greer Deal, Director of Global Regulatory Services (GRS) was there.

Panel members from the UK and Denmark included:

What’s new at the Cambridge Biomedical Campus?

Well if you were at the network meeting on 18 November 2013 you may well know some of the answers but, if you missed it, don't worry because I was there!

End of unlicensed herbal remedies on UK market - deadline 30 April 2014

The UK's MHRA has announced today that "from 30 April 2014, all manufactured herbal medicines will have to be authorised in order to be sold and supplied lawfully in the UK."

"This means that after this date herbal retailers will no longer be able to sell unlicensed herbal medicines that are not registered under the Traditional Herbal Registration (THR) scheme in the UK."

Digital Connectivity in Cities: the role of policy

The Directors of GRS attended a panel discussion in Cambridge on 14 November 2013 about digital connectivity in (UK) cities and the role of policy.  Another excellent event arranged by the Cambridge University Science and Policy Exchange (CUSPE).  The audience consisted of a good cro